Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference

Core Insights - Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing precision cancer medicines [1][3] - The company will participate in a fireside chat at the Guggenheim SMID Cap Biotechnology Conference on February 5, 2025 [1] - The event will be accessible via a live webcast and will be archived for 90 days on the company's website [2] Company Overview - Tango Therapeutics is dedicated to discovering novel drug targets and precision medicine for cancer treatment [3] - The company employs the genetic principle of synthetic lethality to develop therapies targeting critical cancer-related targets [3] - More information about the company can be found on their website [3]